๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Sirolimus-eluting stents for percutaneous coronary intervention in acute myocardial infarction

โœ Scribed by Weber, F. ;Schneider, H. ;Schwarz, C. ;Holzhausen, C. ;Petzsch, M. ;Nienaber, C. A.

Publisher
Springer
Year
2004
Tongue
German
Weight
185 KB
Volume
93
Category
Article
ISSN
0300-5860

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Impact of three or more sirolimus-elutin
Impact of three or more sirolimus-eluting stents versus paclitaxel-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention
โœ William W. Chu; Pramod K. Kuchulakanti; Rebecca Torguson; Betty Wang; Leonardo C ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 75 KB ๐Ÿ‘ 2 views

## Abstract ## Objectives: The purpose of this study was to examine the clinical outcomes of patients who underwent stenting with โ‰ฅ3 sirolimusโ€eluting stents (SES) when compared with those treated with โ‰ฅ3 paclitaxelโ€eluting stents (PES). ## Background: Drugโ€eluting stent (DES) implantation for s

Multicenter international registry of un
Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction
โœ Michael S. Lee; Dario Sillano; Azeem Latib; Alaide Chieffo; Giuseppe Biondi Zocc ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 97 KB ๐Ÿ‘ 2 views

## Abstract Background: Patients who present with myocardial infarction (MI) and unprotected left main coronary artery (ULMCA) disease represent an extremely highโ€risk subset of patients. ULMCA percutaneous coronary intervention (PCI) with drugโ€eluting stents (DES) in MI patients has not been exten